News
GSK's Boostrix for pertussis cleared by FDA for use in pregn...
The FDA has approved use of GlaxoSmithKline’s Boostrix (Tdap) vaccine for use during the third trimester of pregnancy, for prevention of pertussis (whooping cough) in infants younger than t
